Cerevance
Last funding round
Raised
$47,000,000
Round
Unknown
Investors
Led by Agent Capital,Bioluminescence Ventures,Double Point Ventures
Startup details
Cerevance is a Boston, MA-based company focused on developing precision novel therapeutics for central nervous system (CNS) diseases. The company is advancing a pipeline of clinical and preclinical programs, including the lead program, CVN424, an oral, non-dopaminergic compound acting on a novel target (GPR6).
www.cerevance.com
Boston, Massachusetts, United States
Established in 2016
51-200 People
Healthcare, Therapeutics
Founders
Investment details
Founder Stories
Dr. Sterghois Moschos, PulmoBioMed
Recent 5 from Healthcare
May2024
1
1 day ago
San Mateo-based Bluejay Therapeutics develops treatments for viral and liver diseases.
Founders
Dr. Keting Chu
In News
FinSMEs
Thepharmaletter
2
1 day ago
San Francisco-based Triomics develops oncology-specialized generative AI models and use case-specific software for cancer centers.
Founders
Sarim Khan
In News
FinSMEs
Hit Consultant
VentureBeat
Tech Funding News
3
1 day ago
San Diego-based Aardvark Therapeutics is a clinical-stage biopharmaceutical company developing small-molecule therapeutics for metabolic diseases.
Founders
Tien Lee, M.D.
In News
FinSMEs
4
2 days ago
AI-powered personalized sports nutrition app Hexis is expanding into team sports, with usage by Premier League and Championship soccer clubs and Premiership Rugby clubs.
Founders
Professor James Morton,
Sam Impey,
David Dunne,
Stephen Moon
In News
sportsBusinessJournal
endurance.biz
5
2 days ago
Denver-based In-House Health develops AI-driven scheduling platform for nursing teams.
Founders
Ari Brenner,
Sergey Vasilenko,
Shachar Har Zvi
In News
Fierce Healthcare
FinSMEs
Businesswire.com
Recent 5 from United States
May2024
1
1 day ago
Atlanta-based Archive Intel provides AI-driven communications archiving and compliance solutions for firms, managing emails, text messages, and social media.
Founders
Larry Shumbres,
Shea Werner,
Jodi Shumbres
In News
FinSMEs
InvestmentNews
EIN News
2
1 day ago
San Mateo-based Bluejay Therapeutics develops treatments for viral and liver diseases.
Founders
Dr. Keting Chu
In News
FinSMEs
Thepharmaletter
3
1 day ago
San Francisco-based Triomics develops oncology-specialized generative AI models and use case-specific software for cancer centers.
Founders
Sarim Khan
In News
FinSMEs
Hit Consultant
VentureBeat
Tech Funding News
4
1 day ago
Houston-based DoorSpace delivers a cloud-based solution for healthcare professionals to manage personnel and administration.
Founders
Sarah M. Worthy
In News
FinSMEs
Newstrail
5
1 day ago
Milwaukee-based Sift Healthcare delivers AI-powered healthcare payment solutions.
Founders
Justin Nicols,
Robert Mittendorff,
Nick Whitehead
In News
PR Newswire
FinSMEs
BizTimes